1050 Bacillus Calmette-Guerin: One third dose versus full dose and one year versus three years of maintenance. Final results of an EORTC GU Cancers Group randomized trial in non muscle invasive bladder cancer

✍ Scribed by Brausi, M.A.; Oddens, J.R.; Sylvester, R.J.; Bono, A.V.; Van De Beek, C.; Van Andel, G.; Gontero, P.; Hoeltl, W.; Turkeri, L.; Collette, S.; Oosterlinck, W.

• Book ID: 123091020
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 17 KB
• Volume: 11
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(12)61046-X